Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H23N3O |
Molecular Weight | 309.4054 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC(NC(=O)CN2CCC(CC2)C3=NC=CC=C3)=CC=C1
InChI
InChIKey=JFCDMGGMCUKHST-UHFFFAOYSA-N
InChI=1S/C19H23N3O/c1-15-5-4-6-17(13-15)21-19(23)14-22-11-8-16(9-12-22)18-7-2-3-10-20-18/h2-7,10,13,16H,8-9,11-12,14H2,1H3,(H,21,23)
Molecular Formula | C19H23N3O |
Molecular Weight | 309.4054 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16153699Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/19020411
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16153699
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/19020411
A-412,997 or A-412997 is a highly selective agonist for the dopamine D4 receptor. In animal tests, it improved cognitive performance to a similar extent as methylphenidate, but without producing place preference or other signs of abuse liability. When dosed systemically, A-412997 crossed the blood brain barrier rapidly. It was suggested, that selective activation of the D4 receptor, A-412997, might represent a target for the treatment of attention deficit hyperactivity disorder without the potential drug abuse liability associated with current psychostimulant therapies.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16153699
Curator's Comment: Known to be CNS penetrant in rats. Human data not available
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL219 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16153699 |
7.9 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16153699
rats: A-412997 (effective dose=0.1 micromol/kg, s.c.)
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16153699
Curator's Comment: A-412997 is a highly selective dopamine D4 receptor agonist that binds with high affinity to rat dopamine D4 and human dopamine D4.4 receptors (Ki=12.1 and 7.9 nM, respectively). In contrast to the dopamine D4 receptor agonists PD168077 and CP226269, A-412997 showed a better selectivity profile and no affinity <1000 nM for other dopamine receptors or any other proteins in a panel of seventy different receptors and channels. In functional assays using calcium flux, A-412997 was a potent full agonist at rat dopamine D4 receptors (28.4 nM, intrinsic activity=0.83) and did not activate rat dopamine D2L receptors, unlike CP226269.
Unknown
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:34:43 GMT 2023
by
admin
on
Sat Dec 16 08:34:43 GMT 2023
|
Record UNII |
RWL9H93ARB
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
10425450
Created by
admin on Sat Dec 16 08:34:43 GMT 2023 , Edited by admin on Sat Dec 16 08:34:43 GMT 2023
|
PRIMARY | |||
|
A-412997
Created by
admin on Sat Dec 16 08:34:43 GMT 2023 , Edited by admin on Sat Dec 16 08:34:43 GMT 2023
|
PRIMARY | |||
|
DTXSID70212234
Created by
admin on Sat Dec 16 08:34:43 GMT 2023 , Edited by admin on Sat Dec 16 08:34:43 GMT 2023
|
PRIMARY | |||
|
RWL9H93ARB
Created by
admin on Sat Dec 16 08:34:43 GMT 2023 , Edited by admin on Sat Dec 16 08:34:43 GMT 2023
|
PRIMARY | |||
|
630116-49-3
Created by
admin on Sat Dec 16 08:34:43 GMT 2023 , Edited by admin on Sat Dec 16 08:34:43 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |